Insider Monkey analyzed short selling data, revealing trends in US-listed stocks and sectors like technology. AstraZeneca PLC is highlighted as a strong stock with growth potential, supported by strategic decisions and promising drug portfolio. Hedge funds and analysts show confidence in AZN.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing